EUCTR2012-004381-18-NO进行中（未招募）不适用
Treatment of morbid obesity through intra-gastric injections of Botulinum toxin A: A pilot study
St Olavs Hospital Trondheim University Hospital0 个研究点开始时间: 2012年11月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adult (18-60 years) volunteers with morbid obesity (BMI > 40 kgs/m2, or BMI > 35 kgs/m2 if obesity related comorbidity, accepted for bariatric surgery)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 12
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Previous side-effects from botox injections
- •-Previous bariatric surgery
- •-Previous cancer disease in the GI-tract
- •-Other obesity treatment the last 3 mts (drug or lifestyle-based)
- •-Severe binge-eating disorder
- •-Hypothyroidism
- •-Pregnancy
- •-Inadequate capacity to consent
研究者
相似试验
招募中
不适用
aparoscopic surgery for morbid obesitymorbid obesityJPRN-UMIN000010300Frontier Surgery, Chiba University Graduate School of Medicine30
已完成
不适用
aparoscopic Surgery for Severe Obesity combined with gastroesophageal reflux diseaseSevere obesity combined with gastroesophageal reflux diseaseDigestive SystemObesityISRCTN58550318Scientific and Educational Centre for Development of Laparoscopic Surgery in Kazakhstan114
进行中（未招募）
2 期
Intragastric Injections of Botox for the Treatment of ObesityObesity, MorbidNCT02035397Norwegian University of Science and Technology20
招募中
不适用
Introduction of bariatric surgery for morbid obesitymorbid obesityJPRN-UMIN000002720Tohoku University Postgraduate School of Medicine10
尚未招募
不适用
Effects on Non-Alcoholic Steato-Hepatitis (NASH) liver disease, obesity-associated metabolicdisturbances, weight loss, safety and quality of life in adults with NASH and obesity undergoing endoscopic sleeve gastroplasty.on-alcoholic fatty liver diseaseNon-alcoholic fatty liver diseaseMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - ObesityOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonobesityACTRN12618001888257Dr Damian Harding (Chief researcher)10